about
Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cellsMenin stimulates homology-directed DNA repairHIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsCutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variantsMeta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression.Leptin: the prototypic adipocytokine and its role in NAFLD.Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway.T cell metabolism and susceptibility to autoimmune diseases.The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cellsRole of Metabolism in the Immunobiology of Regulatory T Cells.Histone deacetylase 4 promotes ubiquitin-dependent proteasomal degradation of Sp3 in SH-SY5Y cells treated with di(2-ethylhexyl)phthalate (DEHP), determining neuronal death.UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cellsc-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.Immune-metabolic profiling of anorexic patients reveals an anti-oxidant and anti-inflammatory phenotype.Oscillatory mTOR inhibition and Treg increase in kidney transplantation.Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling.Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity.Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease.Intracellular metabolic pathways control immune tolerance.CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasisEditorial: acute inflammation in obesity: IL-17A in the middle of the battleAn immunometabolic pathomechanism for chronic obstructive pulmonary diseaseReduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients
P50
Q24295909-7360D452-5B6C-4FC7-8860-8450A4E17895Q24304240-32FCB177-EAFC-4E7B-B589-511EDF46F971Q34230284-605C0369-5939-4765-8AE3-CB9110CD8A8CQ35097239-E03C3102-DD10-4199-9D1E-21382931D0FEQ35114206-EC64147C-5779-40E2-97DE-67C150111267Q36340576-7CD71097-D0FC-4FD9-8D37-B6EA6A23C3FAQ36847539-9E0A75A3-2D3C-4CA2-B2D6-FEED338B5100Q36904140-36C6F201-D309-4285-B9E5-2D9EDA887994Q37014996-155DF702-93ED-4CA3-938D-3053D93E5B50Q37725018-97C3FB61-342F-4D72-AD96-DD61B26AA8D3Q38339342-0380CAE8-3D00-4FEE-9F5A-E6A4301FE1FBQ38564861-1843EBB3-5B12-44E2-A0A3-9DB85422EB95Q38791198-28F0BFD4-65BE-4389-82F6-AADF12AAEADAQ38957379-FA6FC18C-956A-48C5-B7ED-8D02047DAAF2Q38971078-015913E0-C5DA-495C-B9B7-5A551AAD1EBAQ39252808-F22E271A-CFC5-45BB-ADE8-1BED81698E07Q39436245-B507E7B2-68A3-4C23-9EE4-2C937227D4C5Q39647978-089263D7-2A31-40C4-B758-81FF0698E179Q39771138-0C15744C-8FBB-4A76-97F4-F704F72F3D4EQ40926618-DC35BA69-0C71-423E-82CF-DDB76C99DCFEQ41603104-C4385001-9CA6-43F9-A5CA-BCBF6E0EC345Q42478371-68DF0F77-32C1-4CC8-BA16-6AB528193FCCQ44912942-F81526C4-A6EF-4334-AF38-D347317DB8C8Q46734549-267DF7BF-8195-431D-9FE9-BE207D8183E2Q51045089-CC8B5992-4B5D-4D2D-B10C-0AB0D69D0E3DQ54550722-1655001F-7044-493F-9D80-B4B8631E6BACQ61696162-5D20E4DD-2338-4745-AD31-3FFB2D0C0F9EQ82390199-C62C425E-E3E9-44E2-BFC7-3AB6D8D38BBBQ91901195-8156E942-D5F9-4608-8181-47D2FAAC9B7DQ92964311-5FCECCB3-9055-452F-A5FE-8D7E00BFC2EE
P50
description
researcher
@en
wetenschapper
@nl
name
Mario Galgani
@en
Mario Galgani
@nl
type
label
Mario Galgani
@en
Mario Galgani
@nl
prefLabel
Mario Galgani
@en
Mario Galgani
@nl
P106
P31
P496
0000-0001-8414-1676